1/19
Flashcards covering molecular mechanisms of aging, insulin/IGF-1 signaling, C. elegans dauer genetics, p53-mediated genome integrity, cellular senescence, and telomere biology from Dr Mahmood Alam's lecture.
Progeroid syndromes
Rare genetic disorders characterized by features of accelerated aging, primarily caused by defects in a limited set of cellular functions including genome integrity, nuclear integrity, and metabolism.
age-1
A gene described in 1988 in Caenorhabditis elegans whose recessive, partial loss-of-function mutation doubles post-reproductive adult life expectancy from ∼2 to ∼4 weeks; its normal wild-type function limits adult lifespan by approximately 50%.
daf-23
A gene allelic to age-1 in Caenorhabditis elegans; mutant daf-23 worms continuously form dauer larvae even when supplied with plentiful food, establishing a genetic link between nutrient sensing, dauer development, and aging.
Dauer larva
An alternative developmental arrest state in Caenorhabditis elegans triggered by environmental stresses such as limited food, dense population, and high temperature.
DAF-2
The Caenorhabditis elegans transmembrane receptor orthologous to the mammalian insulin receptor (InsR) and insulin-like growth factor 1 receptor (IGF1-R) that initiates intracellular signalling upon nutrient stimulation.
AGE-1
The Caenorhabditis elegans orthologue of mammalian phosphoinositide 3-kinase (PI3K) that functions directly downstream of DAF-2 in the insulin signalling cascade.
DAF-18
The Caenorhabditis elegans phosphatase orthologous to mammalian PTEN (Phosphatase and tensin homolog) that inhibits the AGE-1 / PI3K signaling pathway.
AKT (Protein kinase B)
A conserved kinase activated downstream of PI3K/AGE-1 that regulates glucose uptake and phosphorylates FOXO/DAF-16 to inhibit its transcriptional activity.
DAF-16
The Caenorhabditis elegans transcription factor orthologous to mammalian Forkhead box O (FOXO); required for the longevity effect of age-1 mutations, it promotes stress resistance, dauer formation, and extended lifespan when activated.
Insulin signalling pathway (vertebrate metabolic effects)
A pathway activated by high calorific intake that promotes cellular glucose uptake from blood, conversion of glucose to glycogen, increased fatty acid synthesis, and esterification of fatty acids into fats in adipose tissue.

Insulin / IGF-1 signalling orthology
A conserved nutrient-sensing cascade between mammals (InsR/IGF1-R → PI3K [inhibited by PTEN] → Akt → FoxO inhibition) and Caenorhabditis elegans (DAF-2 → AGE-1 [inhibited by DAF-18] → AKT → DAF-16 inhibition).
Proteostasis
The maintenance of cellular protein homeostasis, actively promoted by molecular chaperones which are downstream transcriptional targets of DAF-16 and are found at elevated levels in long-lived naked mole rats.
IGF-1 receptor heterozygosity in mice
A genetic condition in mice carrying one inactivated copy of the IGF-1 receptor gene, resulting in a 30% extension in lifespan and increased resistance to oxidative stress.
p53
A transcription factor termed the 'guardian of the genome' that responds to DNA damage, telomere dysfunction, oncogene activation, and reactive oxygen species to trigger DNA repair, cellular senescence, or apoptosis; it is mutated in 50% of all human cancers, predominantly in its DNA-binding domain.

Cellular senescence
A stable, typically irreversible cell cycle arrest regulated by p53 that functions as a tumour suppression defence mechanism, preventing the division of damaged or pre-cancerous cells, while contributing to stem cell depletion during aging.
Hayflick limit
The finite number of population doublings that normal differentiated cells can undergo in culture before entering permanent p53-induced replicative senescence, discovered by Leonard Hayflick in the 1960s.

In vitro population doublings vs. lifespan
The positive correlation between an organism's maximal lifespan and the proliferative capacity of its cells in culture, ranging from mouse (∼20 doublings; 3.5 years), chicken (∼35 doublings; 30 years), and human (∼58 doublings; 120 years) to the Galapagos tortoise (∼125 doublings; 175 years).
Telomeres
Repetitive non-coding DNA sequences (5'-TTAGGG-3' repeats in humans) capping the ends of linear chromosomes that protect genomic DNA from degradation and shorten with successive rounds of cell division.
Chromosome end problem
The inability of conventional DNA polymerase to fully replicate the extreme 5′ end of newly synthesized lagging DNA strands following the removal of terminal RNA primers, resulting in progressive single-stranded loss each cell division cycle.
Telomerase
A specialized ribonucleoprotein enzyme complex comprising a reverse transcriptase catalytic protein and an internal telomerase RNA template, which synthesizes and extends telomeric repeats at the 3′ ends of chromosomes.